Kelly Elise Dooley

Associate Professor

20022019
If you made any changes in Pure, your changes will be visible here soon.

Research Output 2002 2019

2019

Advancing the development of new tuberculosis treatment regimens: The essential role of translational and clinical pharmacology and microbiology

Dooley, K. E., Hanna, D., Mave, V., Eisenach, K. & Savic, R. M., Jul 1 2019, In : PLoS medicine. 16, 7, p. e1002842

Research output: Contribution to journalArticle

Open Access
Clinical Pharmacology
Microbiology
Tuberculosis

Adverse outcome pathway for aminoglycoside ototoxicity in drug-resistant tuberculosis treatment

Hong, H., Dooley, K. E., Starbird, L. E., Francis, H. W. & Farley, J., Jan 1 2019, In : Archives of Toxicology.

Research output: Contribution to journalArticle

Multidrug-Resistant Tuberculosis
Aminoglycosides
Audition
Hearing Loss
Oxidative stress

Alternative dosing guidelines to improve outcomes in childhood tuberculosis: a mathematical modelling study

Radtke, K. K., Dooley, K. E., Dodd, P. J., Garcia-Prats, A. J., McKenna, L., Hesseling, A. C. & Savic, R. M., Sep 1 2019, In : The Lancet. Child & adolescent health. 3, 9, p. 636-645 10 p.

Research output: Contribution to journalArticle

Tuberculosis
Guidelines
Rifampin
Weights and Measures
Nutritional Status

Antiretroviral switching and bedaquiline treatment of drug-resistant tuberculosis HIV co-infection

O'Donnell, M. R., Padayatchi, N., Daftary, A., Orrell, C., Dooley, K. E., Rivet Amico, K. & Friedland, G., Mar 1 2019, In : The Lancet HIV. 6, 3, p. e201-e204

Research output: Contribution to journalComment/debate

bedaquiline
Multidrug-Resistant Tuberculosis
Coinfection
HIV Infections
efavirenz
Open Access
Rifampin
Anti-Infective Agents
Mycobacterium tuberculosis
Positron-Emission Tomography
Names

Intensified antibiotic treatment of tuberculosis meningitis

Cresswell, F. V., Te Brake, L., Atherton, R., Ruslami, R., Dooley, K. E., Aarnoutse, R. & Van Crevel, R., Mar 4 2019, In : Expert Review of Clinical Pharmacology. 12, 3, p. 267-288 22 p.

Research output: Contribution to journalReview article

Meningeal Tuberculosis
Anti-Bacterial Agents
Linezolid
Drug Resistance
Pharmacokinetics

Pharmacokinetic and pharmacodynamic considerations of rifamycin antibiotics for the treatment of tuberculosis

Sekaggya-Wiltshire, C. & Dooley, K. E., Aug 3 2019, In : Expert Opinion on Drug Metabolism and Toxicology. 15, 8, p. 615-618 4 p.

Research output: Contribution to journalEditorial

Open Access
Rifamycins
Pharmacodynamics
Pharmacokinetics
Tuberculosis
Anti-Bacterial Agents

Pharmacologic research in pregnant women — Time to get it right

Eke, A. C., Dooley, K. E. & Sheffield, J., Apr 4 2019, In : New England Journal of Medicine. 380, 14, p. 1293-1295 3 p.

Research output: Contribution to journalReview article

Live Birth
Pregnant Women
Research

The global landscape of tuberculosis therapeutics

Tornheim, J. & Dooley, K. E., Jan 27 2019, In : Annual Review of Medicine. 70, p. 105-120 16 p.

Research output: Contribution to journalReview article

Tuberculosis
Pharmaceutical Preparations
Extensively Drug-Resistant Tuberculosis
Latent Tuberculosis
Therapeutics
2018

A Mechanism-Based Population Pharmacokinetic Analysis Assessing the Feasibility of Efavirenz Dose Reduction to 400 mg in Pregnant Women

Schalkwijk, S., Ter Heine, R., Colbers, A. C., Huitema, A. D. R., Denti, P., Dooley, K. E., Capparelli, E., Best, B. M., Cressey, T. R., Greupink, R., Russel, F. G. M., Mirochnick, M. & Burger, D. M., Mar 8 2018, (Accepted/In press) In : Clinical Pharmacokinetics. p. 1-13 13 p.

Research output: Contribution to journalArticle

efavirenz
Pregnant Women
Pharmacokinetics
Pregnancy
Population

Challenges of TB and HIV co-treatment: updates and insights

Tornheim, J. & Dooley, K. E., Nov 1 2018, In : Current Opinion in HIV and AIDS. 13, 6, p. 486-491 6 p.

Research output: Contribution to journalArticle

Tuberculosis
HIV
Multidrug-Resistant Tuberculosis
Therapeutics
Routine Diagnostic Tests

Effect of Diabetes Mellitus on the Pharmacokinetics and Pharmacodynamics of Tuberculosis Treatment

Alfarisi, O., Mave, V., Gaikwad, S., Sahasrabudhe, T., Ramachandran, G., Kumar, H., Gupte, N., Kulkarni, V., Deshmukh, S., Atre, S., Raskar, S., Lokhande, R., Barthwal, M., Kakrani, A., Chon, S., Gupta, A., Golub, J. E. & Dooley, K. E., Nov 1 2018, In : Antimicrobial Agents and Chemotherapy. 62, 11

Research output: Contribution to journalArticle

Pyrazinamide
Diabetes Mellitus
Tuberculosis
Pharmacokinetics
Isoniazid

High-dose rifampin: Shall we be bolder?

Dooley, K. E., Sep 1 2018, In : American Journal of Respiratory and Critical Care Medicine. 198, 5, p. 558-560 3 p.

Research output: Contribution to journalEditorial

Rifampin

Levofloxacin population pharmacokinetics in south african children treated for multidrug-resistant tuberculosis

Denti, P., Garcia-Prats, A. J., Draper, H. R., Wiesner, L., Winckler, J., Thee, S., Dooley, K. E., Savic, R. M., McIlleron, H. M., Simon Schaaf, H. & Hesseling, A. C., Feb 1 2018, In : Antimicrobial Agents and Chemotherapy. 62, 2, e01521-17.

Research output: Contribution to journalArticle

Multidrug-Resistant Tuberculosis
Levofloxacin
Pharmacokinetics
Weights and Measures
Population
Tuberculosis
Injections
Therapeutics

Pharmacokinetics of rifapentine and rifampin in a rabbit model of tuberculosis and correlation with clinical trial data

Rifat, D., Prideaux, B., Savic, R. M., Urbanowski, M. E., Parsons, T. L., Luna, B., Marzinke, M. A., Ordonez Suarez, A., DeMarco, V. P., Jain, S., Dartois, V., Bishai, W. R. & Dooley, K. E., Apr 4 2018, In : Science Translational Medicine. 10, 435, eaai7786.

Research output: Contribution to journalArticle

rifapentine
Rifampin
Tuberculosis
Pharmacokinetics
Clinical Trials

Poor Obstetric and Infant Outcomes in Human Immunodeficiency Virus-Infected Pregnant Women with Tuberculosis in South Africa: The Tshepiso Study

Salazar-Austin, N., Hoffmann, J., Cohn, S., Mashabela, F., Waja, Z., Lala, S., Hoffmann, C., Dooley, K. E., Chaisson, R. E. & Martinson, N., Mar 5 2018, In : Clinical Infectious Diseases. 66, 6, p. 921-929 9 p.

Research output: Contribution to journalArticle

South Africa
Obstetrics
Pregnant Women
Tuberculosis
HIV
Meningeal Tuberculosis
Tuberculosis
Pediatrics
Therapeutics
Rabbits

State-of-the-Art Review of HIV-TB Coinfection in Special Populations

Weld, E. & Dooley, K. E., Dec 1 2018, In : Clinical Pharmacology and Therapeutics. 104, 6, p. 1098-1109 12 p.

Research output: Contribution to journalReview article

Coinfection
Tuberculosis
HIV
Population
Postpartum Period

Suboptimal Antituberculosis Drug Concentrations and Outcomes in Small and HIV-Coinfected Children in India: Recommendations for Dose Modifications

Guiastrennec, B., Ramachandran, G., Karlsson, M. O., Kumar, A. K. H., Bhavani, P. K., Gangadevi, N. P., Swaminathan, S., Gupta, A., Dooley, K. E. & Savic, R. M., Jan 1 2018, (Accepted/In press) In : Clinical Pharmacology and Therapeutics.

Research output: Contribution to journalArticle

Rifampin
India
HIV
Guidelines
Pediatrics

The Global Neurological Burden of Tuberculosis

Thakur, K., Das, M., Dooley, K. E. & Gupta, A., Apr 1 2018, In : Seminars in Neurology. 38, 2, p. 226-237 12 p., 180017.

Research output: Contribution to journalArticle

Central Nervous System Tuberculosis
Meningeal Tuberculosis
Tuberculosis
Intracranial Tuberculoma
Internal Capsule

The utility of pharmacokinetic studies for the evaluation of exposure-response relationships for standard dose anti-tuberculosis drugs

Sekaggya-Wiltshire, C., Lamorde, M., Kiragga, A. N., Dooley, K. E., Kamya, M. R., Kambugu, A., Fehr, J., Manabe, Y. C. & Castelnuovo, B., Jan 1 2018, In : Tuberculosis. 108, p. 77-82 6 p.

Research output: Contribution to journalReview article

Tuberculosis
Pharmacokinetics
Pharmaceutical Preparations
Pulmonary Tuberculosis
Public Health
2017

Bedaquiline

Tornheim, J. & Dooley, K. E., Jan 1 2017, Kucers the Use of Antibiotics: A Clinical Review of Antibacterial, Antifungal, Antiparasitic, and Antiviral Drugs, Seventh Edition. CRC Press, p. 2542-2549 8 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

bedaquiline
Multidrug-Resistant Tuberculosis
Mortality
Isoniazid
Rifampin

Defining the optimal dose of rifapentine for pulmonary tuberculosis: Exposure-response relations from two phase II clinical trials

Savic, R. M., Weiner, M., Mackenzie, W. R., Engle, M., Whitworth, W. C., Johnson, J. L., Nsubuga, P., Nahid, P., Nguyen, N. V., Peloquin, C. A., Dooley, K. E. & Dorman, S. E., 2017, (Accepted/In press) In : Clinical Pharmacology and Therapeutics.

Research output: Contribution to journalArticle

rifapentine
Phase II Clinical Trials
Pulmonary Tuberculosis
Pharmacokinetics
Therapeutics

Importance of Drug Pharmacokinetics at the Site of Action

Rizk, M. L., Zou, L., Savic, R. M. & Dooley, K. E., May 1 2017, In : Clinical and Translational Science. 10, 3, p. 133-142 10 p.

Research output: Contribution to journalReview article

In vitro and in vivo activity of biapenem against drug-susceptible and rifampicin-resistant Mycobacterium tuberculosis

Kaushik, A., Ammerman, N., Tasneen, R., Story-Roller, E., Dooley, K. E., Dorman, S. E., Nuermberger, E. & Lamichhane, G., Aug 1 2017, In : Journal of Antimicrobial Chemotherapy. 72, 8, p. 2320-2325 6 p., dkx152.

Research output: Contribution to journalArticle

biapenem
Rifampin
Mycobacterium tuberculosis
Pharmaceutical Preparations
In Vitro Techniques

Isoniazid concentrations in hair and plasma area-under-the-curve exposure among children with tuberculosis

Mave, V., Kinikar, A., Kagal, A., Nimkar, S., Koli, H., Khwaja, S., Bharadwaj, R., Gerona, R., Wen, A., Ramachandran, G., Kumar, H., Bacchetti, P., Dooley, K. E., Gupte, N., Gupta, A. & Gandhi, M., Dec 1 2017, In : PLoS One. 12, 12, e0189101.

Research output: Contribution to journalArticle

isoniazid
Isoniazid
tuberculosis
Hair
Area Under Curve

Management of tuberculosis in special populations

Salazar-Austin, N., Jain, S. & Dooley, K. E., Mar 30 2017, Handbook of Tuberculosis. Springer International Publishing, p. 141-190 50 p.

Research output: Chapter in Book/Report/Conference proceedingChapter

Tuberculosis

New Paradigm for Translational Modeling to Predict Long-term Tuberculosis Treatment Response

Bartelink, I. H., Zhang, N., Keizer, R. J., Strydom, N., Converse, P. J., Dooley, K. E., Nuermberger, E. & Savic, R. M., 2017, (Accepted/In press) In : Clinical and Translational Science.

Research output: Contribution to journalArticle

Tuberculosis
rifapentine
Pharmacokinetics
Confidence Intervals
Rifampin

Pediatric multidrug-resistant tuberculosis clinical trials: challenges and opportunities

McAnaw, S. E., Hesseling, A. C., Seddon, J. A., Dooley, K. E., Garcia-Prats, A. J., Kim, S., Jenkins, H. E., Schaaf, H. S., Sterling, T. R. & Horsburgh, C. R., Mar 1 2017, In : International Journal of Infectious Diseases. 56, p. 194-199 6 p.

Research output: Contribution to journalReview article

Multidrug-Resistant Tuberculosis
Clinical Trials
Pediatrics
Tuberculosis
Therapeutics

Population pharmacokinetics of pyrazinamide in patients with tuberculosis

Alsultan, A., Savic, R., Dooley, K. E., Weiner, M., Whitworth, W., MacKenzie, W. R. & Peloquin, C. A., Jun 1 2017, In : Antimicrobial Agents and Chemotherapy. 61, 6, e02625-16.

Research output: Contribution to journalArticle

Pyrazinamide
Tuberculosis
Pharmacokinetics
Population
Area Under Curve

Prevention of TB using rifampicin plus isoniazid reduces nevirapine concentrations in HIV-exposed infants

on behalf of the Tshepiso Study Team, Jul 1 2017, In : Journal of Antimicrobial Chemotherapy. 72, 7, p. 2028-2034 7 p., dkx112.

Research output: Contribution to journalArticle

Nevirapine
Isoniazid
Rifampin
HIV
Therapeutics

Priority-Setting for Novel Drug Regimens to Treat Tuberculosis: An Epidemiologic Model

Kendall, E., Shrestha, S., Cohen, T., Nuermberger, E., Dooley, K. E., Gonzalez-Angulo, L., Churchyard, G. J., Nahid, P., Rich, M. L., Bansbach, C., Forissier, T., Lienhardt, C. & Dowdy, D. W., Jan 1 2017, In : PLoS Medicine. 14, 1, e1002202.

Research output: Contribution to journalArticle

Rifampin
Tuberculosis
Uncertainty
Pharmaceutical Preparations
Mortality

Rifampin vs. rifapentine: what is the preferred rifamycin for tuberculosis?

Alfarisi, O., Alghamdi, W. A., Al-Shaer, M. H., Dooley, K. E. & Peloquin, C. A., Aug 19 2017, (Accepted/In press) In : Expert Review of Clinical Pharmacology. p. 1-10 10 p.

Research output: Contribution to journalArticle

rifapentine
Rifampin
Latent Tuberculosis
Tuberculosis
Drug Interactions

The epidemiology, pathogenesis, transmission, diagnosis, and management of multidrug-resistant, extensively drug-resistant, and incurable tuberculosis

Dheda, K., Gumbo, T., Maartens, G., Dooley, K. E., McNerney, R., Murray, M., Furin, J., Nardell, E. A., London, L., Lessem, E., Theron, G., van Helden, P., Niemann, S., Merker, M., Dowdy, D. W., Van Rie, A., Siu, G. K. H., Pasipanodya, J. G., Rodrigues, C., Clark, T. G. & 22 others, Sirgel, F. A., Esmail, A., Lin, H. H., Atre, S. R., Schaaf, H. S., Chang, K. C., Lange, C., Nahid, P., Udwadia, Z. F., Horsburgh, C. R., Churchyard, G. J., Menzies, D., Hesseling, A. C., Nuermberger, E., McIlleron, H., Fennelly, K. P., Goemaere, E., Jaramillo, E., Low, M., Jara, C. M., Padayatchi, N. & Warren, R. M., Apr 1 2017, In : The Lancet Respiratory Medicine. 5, 4, p. 291-360 70 p.

Research output: Contribution to journalReview article

Extensively Drug-Resistant Tuberculosis
Epidemiology
Tuberculosis
Multidrug-Resistant Tuberculosis
Linezolid

The time has come: sparing injectables in paediatric MDR-TB

Weld, E., Garcia-Prats, A. J., Furin, J. J., Bailey, T. C., Hesseling, A. C. & Dooley, K. E., Apr 1 2017, In : The Lancet Respiratory Medicine. 5, 4, p. 245-246 2 p.

Research output: Contribution to journalComment/debate

Pediatrics
Injections

Tuberculosis Associated with HIV Infection

Tornheim, J. & Dooley, K. E., Jan 1 2017, In : Microbiology spectrum. 5, 1

Research output: Contribution to journalReview article

tuberculosis
human immunodeficiency virus
HIV Infections
Tuberculosis
HIV

Tuberculous meningitis

on behalf of the Tuberculous Meningitis International Research Consortium, Oct 1 2017, In : Nature Reviews Neurology. 13, 10, p. 581-598 18 p.

Research output: Contribution to journalReview article

Meningeal Tuberculosis
Tuberculosis
Anti-Bacterial Agents
Culture Techniques
Thalidomide
2016

A new trial design to accelerate tuberculosis drug development: The Phase IIC Selection Trial with Extended Posttreatment follow-up (STEP)

Phillips, P. P. J., Dooley, K. E., Gillespie, S. H., Heinrich, N., Stout, J. E., Nahid, P., Diacon, A. H., Aarnoutse, R. E., Kibiki, G. S., Boeree, M. J. & Hoelscher, M., 2016, In : BMC Medicine. 14, 1, 51.

Research output: Contribution to journalArticle

Tuberculosis
Pharmaceutical Preparations
Random Allocation
Treatment Failure
Communicable Diseases

A phase 2 randomized trial of a rifapentine plus moxifloxacin-based regimen for treatment of pulmonary tuberculosis

Conde, M. B., Mello, F. C. Q., Duarte, R. S., Cavalcante, S. C., Rolla, V., Dalcolmo, M., Loredo, C., Durovni, B., Armstrong, D. T., Efron, A., Link Barnes, G., Marzinke, M. A., Savic, R. M., Dooley, K. E., Cohn, S., Moulton, L. H., Chaisson, R. E. & Dorman, S. E., May 1 2016, In : PLoS One. 11, 5, e0154778.

Research output: Contribution to journalArticle

rifapentine
Pulmonary Tuberculosis
tuberculosis
lungs
isoniazid

Cohort for Tuberculosis Research by the Indo-US Medical Partnership (CTRIUMPH): Protocol for a multicentric prospective observational study

Gupte, A., Padmapriyadarsini, C., Mave, V., Kadam, D., Suryavanshi, N., Shivakumar, S. V. B. Y., Kohli, R., Gupte, N., Thiruvengadam, K., Kagal, A., Meshram, S., Bharadwaj, R., Khadse, S., Ramachandran, G., Hanna, L. E., Pradhan, N., Gomathy, N. S., Deluca, A., Gupta, A., Swaminathan, S. & 73 others, Kinikar, A., Raja, A., Nagraj, A., Anand Kumar, B., More, A., Gaikwad, A., Nangude, A., Balaji, S., Thomas, B., Joseph, B., Bharath, T. K., Brindha, B., Dowdy, D. W., Pole, D., Devanathan, A., Devi Sangamithrai, M., Jain, D., Dolla, C. K., Smit, G., Gangadarsharma, R., Chaugule, H., Koli, H., Hemanthkumar, Jeeva, J., Elf, J., Golub, J. E., Chandane, J., Savita, K., Kannan, M., Karthikesh, M., Karunakaran, S., Dooley, K. E., Murali, L., Lavanya, M., Madasamy, S., Mageshkumar, M., Mangaiyarkarasi, S., Gujare, M., Manoharan, S., Michel Premkumar, M., Munivardhan, P., Murugesan, S., Gomathy, N. S., Nagaraj, Ponnuraja, C., Premkumar, N., Lokhande, R., Rajkumar, S., Ranganathan, K., Rani, S., Madewar, R., Bollinger, R. C., Warlick, R., Shivakoti, R., Javanjal, S., Sathyamurthi, P., Pawar, S., Hande, S., Muley, S., Sali, S., Shubhapriya, K., Biswal, S., Silambu Chelvi, K., Nimkar, S., Selvaraj, S., Salvi, S., Raskar, S., Devi, U., Kulkarni, V., Hulyalkar, V., Tayawade, V., Bansode, V. & Daware, Y., 2016, In : BMJ Open. 6, 2, e010542.

Research output: Contribution to journalArticle

Observational Studies
Tuberculosis
Prospective Studies
Research
Biomarkers

Drug-resistant tuberculosis clinical trials: Proposed core research definitions in adults

Furin, J., Alirol, E., Allen, E., Fielding, K., Merle, C., Abubakar, I., Andersen, J., Davies, G., Dheda, K., Diacon, A., Dooley, K. E., Dravnice, G., Eisenach, K., Everitt, D., Ferstenberg, D., Goolam-Mahomed, A., Grobusch, M. P., Gupta, R., Harausz, E., Harrington, M. & 13 others, Horsburgh, C. R., Lienhardt, C., McNeeley, D., Mitnick, C. D., Nachman, S., Nahid, P., Nunn, A. J., Phillips, P., Rodriguez, C., Shah, S., Wells, C., Thomas-Nyang'wa, B. & Du Cros, P., Mar 1 2016, In : International Journal of Tuberculosis and Lung Disease. 20, 3, p. 290-294 5 p.

Research output: Contribution to journalArticle

Multidrug-Resistant Tuberculosis
Clinical Trials
Research
Manuscripts
Pharmaceutical Preparations

Isoniazid hair concentrations in children with tuberculosis: A proof of concept study

Mave, V., Chandanwale, A., Kinikar, A., Khadse, S., Kagal, A., NGupte, N., Suryavanshi, N., Nimkar, S., Koli, H., Khwaja, S., Bharadwaj, R., Joshi, S., Horng, H., Benet, L. Z., Ramachandran, G., Dooley, K. E., Gupta, A. & Gandhi, M., Jun 1 2016, In : International Journal of Tuberculosis and Lung Disease. 20, 6, p. 844-847 4 p.

Research output: Contribution to journalArticle

Isoniazid
Hair
Tuberculosis
Drug Monitoring
Liquid Chromatography

Pharmacokinetic Interactions for Drugs with a Long Half-Life—Evidence for the Need of Model-Based Analysis

Svensson, E. M., Acharya, C., Clauson, B., Dooley, K. E. & Karlsson, M. O., Jan 1 2016, In : AAPS Journal. 18, 1, p. 171-179 9 p.

Research output: Contribution to journalArticle

Drug Interactions
Pharmacokinetics
bedaquiline
Pharmaceutical Preparations
Half-Life

Population Pharmacokinetics of Rifampin in Pregnant Women with Tuberculosis and HIV Coinfection in Soweto, South Africa

on behalf of the Tshepiso Study Team & Martinson, N., Mar 1 2016, In : Antimicrobial Agents and Chemotherapy. 60, 3, p. 1234-1241 8 p.

Research output: Contribution to journalArticle

Rifampin
South Africa
Coinfection
Pregnant Women
Tuberculosis

Treatment Failure, Drug Resistance, and CD4 T-Cell Count Decline among Postpartum Women on Antiretroviral Therapy in South Africa

Hoffmann, C., Cohn, S., Mashabela, F., Hoffmann, J. D., McIlleron, H., Denti, P., Haas, D. W., Dooley, K. E., Martinson, N. A. & Chaisson, R. E., Jan 1 2016, In : Journal of Acquired Immune Deficiency Syndromes. 71, 1, p. 31-37 7 p.

Research output: Contribution to journalArticle

CD4 Lymphocyte Count
South Africa
Treatment Failure
Drug Resistance
Postpartum Period
2015

Challenges in the clinical assessment of novel tuberculosis drugs

Dooley, K. E., Phillips, P. P. J., Nahid, P. & Hoelscher, M., Sep 24 2015, (Accepted/In press) In : Advanced Drug Delivery Reviews.

Research output: Contribution to journalArticle

Tuberculosis
Pharmaceutical Preparations
Imagination
Biomarkers
Clinical Trials

Daily rifapentine for treatment of pulmonary tuberculosis: A randomized, dose-ranging trial

Dorman, S. E., Feb 1 2015, In : American Journal of Respiratory and Critical Care Medicine. 191, 3, p. 333-343 11 p.

Research output: Contribution to journalArticle

rifapentine
Pulmonary Tuberculosis
Rifampin
Sputum
Therapeutics

Determination of [11C]rifampin pharmacokinetics within Mycobacterium tuberculosis-infected mice by using dynamic positron emission tomography bioimaging

DeMarco, V. P., Ordonez Suarez, A., Klunk, M., Prideaux, B., Wang, H., Zhuo, Z., Tonge, P. J., Dannals, R. F., Holt, D., Lee, C. K., Weinstein, E. A., Dartois, V., Dooley, K. E. & Jain, S., Sep 1 2015, In : Antimicrobial Agents and Chemotherapy. 59, 9, p. 5768-5774 7 p.

Research output: Contribution to journalArticle

Rifampin
Mycobacterium tuberculosis
Positron-Emission Tomography
Pharmacokinetics
Pharmaceutical Preparations